{"id":"https://openalex.org/W7213909855","doi":"https://doi.org/10.1016/j.bict.2026.100090","title":"Epcoritamab and glofitamab as bridging therapy prior to CAR T-cell therapy in relapsed/refractory large B-cell lymphoma","display_name":"Epcoritamab and glofitamab as bridging therapy prior to CAR T-cell therapy in relapsed/refractory large B-cell lymphoma","publication_year":2026,"publication_date":"2026-09-21","ids":{"openalex":"https://openalex.org/W7213909855","doi":"https://doi.org/10.1016/j.bict.2026.100090"},"language":"en","primary_location":{"id":"doi:10.1016/j.bict.2026.100090","doi":"https://doi.org/10.1016/j.bict.2026.100090","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.bict.2026.100090","pdf_url":null,"source":{"id":"https://openalex.org/S5407047417","display_name":"Blood Immunology & Cellular Therapy","issn_l":"3050-5976","issn":["3050-5976"],"is_oa":true,"is_in_doaj":true,"is_core":false,"listed_in":["doaj"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood Immunology & Cellular Therapy","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.1016/j.bict.2026.100090","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5075280655","display_name":"Pauline Piazzola","orcid":"https://orcid.org/0009-0002-9780-2933","observed_orcids":["https://orcid.org/0009-0002-9780-2933"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Pauline Piazzola","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0009-0002-9780-2933","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5065927270","display_name":"Edmond Chiche","orcid":"https://orcid.org/0000-0002-5529-3299","observed_orcids":["https://orcid.org/0000-0002-5529-3299"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Edmond Chiche","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5119662215","display_name":"Lydia Cherfaoui","orcid":"https://orcid.org/0009-0002-2572-186X","observed_orcids":["https://orcid.org/0009-0002-2572-186X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Lydia Cherfaoui","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0009-0002-2572-186X","affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5024799173","display_name":"Gabriel Brisou","orcid":"https://orcid.org/0000-0003-0771-683X","observed_orcids":["https://orcid.org/0000-0003-0771-683X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Gabriel Brisou","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-0771-683X","affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":3000,"currency":"USD","value_usd":3000},"apc_paid":{"value":3000,"currency":"USD","value_usd":3000},"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"2","issue":"4","first_page":"100090","last_page":"100090"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11491","display_name":"CAR-T cell therapy research","score":0.9496999979019165,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11491","display_name":"CAR-T cell therapy research","score":0.9496999979019165,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.039500001817941666,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":0.00139999995008111,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/epcoritamab","display_name":"epcoritamab","score":0.9879999756813049},{"id":"https://openalex.org/keywords/glofitamab","display_name":"glofitamab","score":0.9990000128746033},{"id":"https://openalex.org/keywords/bridging-therapy","display_name":"bridging therapy","score":0.8970000147819519},{"id":"https://openalex.org/keywords/car-t-cell-therapy","display_name":"CAR T-cell therapy","score":0.968999981880188},{"id":"https://openalex.org/keywords/relapsed-refractory-large-b-cell-lymphoma","display_name":"relapsed/refractory large B-cell lymphoma","score":0.9639999866485596},{"id":"https://openalex.org/keywords/bispecific-antibodies","display_name":"bispecific antibodies","score":0.527999997138977},{"id":"https://openalex.org/keywords/antibody-drug-conjugates","display_name":"antibody-drug conjugates","score":0.5600000023841858}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7922999858856201},{"id":"https://openalex.org/C174348530","wikidata":"https://www.wikidata.org/wiki/Q188635","display_name":"Bridging (networking)","level":2,"score":0.539900004863739},{"id":"https://openalex.org/C2779338263","wikidata":"https://www.wikidata.org/wiki/Q208414","display_name":"Lymphoma","level":2,"score":0.5092999935150146},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.42419999837875366},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.41749998927116394},{"id":"https://openalex.org/C509974204","wikidata":"https://www.wikidata.org/wiki/Q180507","display_name":"Radiation therapy","level":2,"score":0.413100004196167},{"id":"https://openalex.org/C2908856526","wikidata":"https://www.wikidata.org/wiki/Q16252627","display_name":"Antibody therapy","level":4,"score":0.32989999651908875},{"id":"https://openalex.org/C2911194787","wikidata":"https://www.wikidata.org/wiki/Q5099363","display_name":"CAR T-cell therapy","level":5,"score":0.3163999915122986},{"id":"https://openalex.org/C2776146153","wikidata":"https://www.wikidata.org/wiki/Q7281276","display_name":"Radioimmunotherapy","level":4,"score":0.27300000190734863},{"id":"https://openalex.org/C2779473830","wikidata":"https://www.wikidata.org/wiki/Q1540899","display_name":"MEDLINE","level":2,"score":0.26930001378059387},{"id":"https://openalex.org/C2983331546","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer therapy","level":3,"score":0.2669999897480011},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.25290000438690186}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1016/j.bict.2026.100090","doi":"https://doi.org/10.1016/j.bict.2026.100090","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.bict.2026.100090","pdf_url":null,"source":{"id":"https://openalex.org/S5407047417","display_name":"Blood Immunology & Cellular Therapy","issn_l":"3050-5976","issn":["3050-5976"],"is_oa":true,"is_in_doaj":true,"is_core":false,"listed_in":["doaj"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood Immunology & Cellular Therapy","raw_type":"journal-article"}],"best_oa_location":{"id":"doi:10.1016/j.bict.2026.100090","doi":"https://doi.org/10.1016/j.bict.2026.100090","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.bict.2026.100090","pdf_url":null,"source":{"id":"https://openalex.org/S5407047417","display_name":"Blood Immunology & Cellular Therapy","issn_l":"3050-5976","issn":["3050-5976"],"is_oa":true,"is_in_doaj":true,"is_core":false,"listed_in":["doaj"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood Immunology & Cellular Therapy","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.9476000070571899,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":17,"referenced_works":["https://openalex.org/W4200201081","https://openalex.org/W4285795354","https://openalex.org/W4311537867","https://openalex.org/W4312115076","https://openalex.org/W4318762931","https://openalex.org/W4389259020","https://openalex.org/W4395114014","https://openalex.org/W4396593055","https://openalex.org/W4402827909","https://openalex.org/W4407007830","https://openalex.org/W4411322829","https://openalex.org/W4411322849","https://openalex.org/W4411879578","https://openalex.org/W4417015694","https://openalex.org/W7116844175","https://openalex.org/W7129565344","https://openalex.org/W7161179089"],"related_works":["https://openalex.org/W4417009818","https://openalex.org/W4316663716","https://openalex.org/W7161179089","https://openalex.org/W4411187617","https://openalex.org/W4388824977","https://openalex.org/W4401877783","https://openalex.org/W7204735571","https://openalex.org/W4417012642","https://openalex.org/W4417008276","https://openalex.org/W4411325872"],"abstract_inverted_index":null,"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2026-09-22T00:00:00"}